BELLUS Health Inc.
BLU · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.47 | -0.13 | -0.56 | -0.12 |
| FCF Yield | -10.33% | -10.89% | -16.77% | -4.76% |
| EV / EBITDA | -11.85 | -6.72 | -4.17 | -20.48 |
| Quality | ||||
| ROIC | -19.87% | -24.95% | -22.34% | -29.55% |
| Gross Margin | -21,967,104.08% | -13,887,173.94% | -9,536,119.55% | -3,711,740.75% |
| Cash Conversion Ratio | 1.01 | 0.86 | 0.94 | 0.81 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.17% | -15.79% | -16.43% | -41.11% |
| Free Cash Flow Growth | -40.95% | -129.58% | -20.70% | -235.85% |
| Safety | ||||
| Net Debt / EBITDA | 1.18 | 2.05 | 1.53 | 0.74 |
| Interest Coverage | -998.50 | -1,332.44 | -844.67 | -1,136.67 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 1,110,981,915.50 | 0.00 | -29.06 |
| Cash Conversion Cycle | 37,480.47 | 31,229.84 | 25,525.50 | 17,287.53 |